Kisqali Femara Co-Pack 600 mg-2.5 mg Dose

Generic name:letrozole and ribociclib [ LET-roe-zol-and-RYE-boe-SYE-klib ]
Brand names: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack 400 mg-2.5 mg Dose, Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Drug class:Antineoplastic combinations

Medically reviewed by Drugs.com on Jul 14, 2020. Written by Cerner Multum.

What is Kisqali Femara Co-Pack 600 mg-2.5 mg Dose?

Kisqali Femara Co-Pack 600 mg-2.5 mg Dose are used together in combination to treat HR-positive, HER2-negative breast cancer.

KisqaliFemara Co-Pack 600 mg-2.5 mg Dose is used when the cancer has spread to other parts of the body (metastatic).

Kisqali Femara Co-Pack 600 mg-2.5 mg Dose are two different medicines that are packaged together. Letrozole tablets are yellow and ribociclib tablets are violet.

Kisqali Femara Co-Pack 600 mg-2.5 mg Dose may also be used for purposes not listed in this medication guide.

Warnings

This medicine can cause a serious heart rhythm or lung problem. Call your doctor at once if you have fast or pounding heartbeats, severe dizziness, chest pain, or shortness of breath.

Kisqali Femara Co-Pack 600 mg-2.5 mg Dose may also affect your liver or blood cells. Tell your doctor if you have right-sided stomach pain, tiredness, flu-symptoms, easy bruising or bleeding, dark urine, or yellowing of the skin or eyes.

This medicine may also cause a severe skin reaction. Get emergency medical ...